AZN
AstraZeneca PLC

18,751
Loading...
Loading...
News
all
press releases
OLMA Stock Soars 47% in September So Far on Second PFE Deal
Olema Pharmaceuticals surges 47% in September after striking a second collaboration with Pfizer for its lead breast cancer product candidate, palazestrant.
Zacks·2d ago
News Placeholder
More News
News Placeholder
Pfizer's Late-Stage Pipeline Fuels Long-Term Growth Prospects
Pfizer's late-stage pipeline, from oncology blockbusters to mRNA vaccines, positions it for long-term growth despite recent setbacks.
Zacks·2d ago
News Placeholder
Is BDTX's Cash balance Enough to Successfully Develop Its NSCLC Drug?
Black Diamond sharpens focus on silevertinib after outlicensing BDTX-4933, cutting costs, and securing cash runway into late 2027.
Zacks·2d ago
News Placeholder
The Zacks Analyst Blog Highlights Oracle, AstraZeneca, Shopify and Blue Ridge Bankshares
Oracle, AstraZeneca, Shopify, and Blue Ridge Bankshares show strong growth and strategic market opportunities.
Zacks·2d ago
News Placeholder
Top Research Reports for Oracle, AstraZeneca & Shopify
Oracle's cloud boom, AstraZeneca's drug pipeline, and Shopify's AI tools headline fresh analyst reports on major stocks.
Zacks·3d ago
News Placeholder
J&J Gains FDA Approval for Inlexzoh, Strengthens Pipeline Momentum
J&J secures FDA approval for Inlexzoh, which boosts its Innovative Medicine pipeline and reinforces long-term growth momentum.
Zacks·4d ago
News Placeholder
LLY's Phase III Study on Jaypirca in Front-Line Leukemia Meets Goal
Lilly's Jaypirca shows a strong survival benefit over chemoimmunotherapy in treatment-naive CLL/SLL, boosting its potential in front-line use.
Zacks·5d ago
News Placeholder
Will LLY's Oncology Portfolio Provide Key Diversification Benefits?
Eli Lilly's oncology portfolio, led by Verzenio and Jaypirca, is adding diversification to its cardiometabolic-driven growth story.
Zacks·5d ago
News Placeholder
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·5d ago
News Placeholder
Why Astrazeneca (AZN) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·6d ago

Latest AZN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.